Supporting scientists answering the most complex questions in cancer

Our Research Programs
Our Portfolio

latest news


Novel Grant Opportunity Focused on the Science of the Patient Announced with AACR

Read More

A Note on COVID-19/Novel Coronavirus

Read More

Partnership with Chordoma Foundation Announced to Fund Open-Source Research to Accelerate Drug Discovery

Read More

New Cancer Center Established at Johns Hopkins University

Read More

Our Mission


The Mark Foundation for Cancer Research supports cutting-edge, innovative scientific ideas that will answer the most complex questions about cancer biology and lead to new and better ways to prevent, diagnose, and treat the disease.

The Mark Foundation pursues its mission by supporting a global portfolio of groundbreaking research carried out by individual investigators, multi-investigator teams, and inter-institutional collaborations.

Recognizing the obstacles that can prevent scientific advances from improving patient outcomes, The Mark Foundation maintains a nimble, high-impact approach to funding research that encompasses grants for basic, translational, and clinical cancer research, as well as venture philanthropy investment in companies that bridge the gap between bench and bedside.

Our Grant Portfolio


100 Grants

Over $90 Million Awarded


  • 43% Translational Science
  • 26% Technology Innovation
  • 23% Basic Research
  • 5% Therapeutic Discovery
  • 3% Clinical

Funding By Cancer Type


  • 47% All cancer types
  • 9% Others
  • 9% Leukemia
  • 8% Brain Tumors
  • 7% Melanoma
  • 6% Breast Cancer
  • 4% Pancreatic Cancer
  • 3% Colorectal Cancer
  • 3% Lung Cancer
  • 2% Lymphoma
  • 1% Ovarian Cancer
  • 1% Prostate Cancer

Over 50 Institutions

In 6 Countries


  • CANADA
  • NETHERLANDS
  • DENMARK
  • UNITED KINGDOM
  • FRANCE
  • USA